Skip to content

Revolution Medicines, Inc.

RVMD RVMDW

CIK 0001628171

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$1.22B
−88.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$6.34
−66.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$781.28M
Q1 May 2026
Cash
$440.94M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
212.6M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings